LAMEA IVD Market Expected to Reach $10,316 million by 2023

Reagents occupied the highest share of the market in 2016 and is expected to maintain the lead during the forecast period owing to wide availability of cost-effective reagents and new reagents produced to perform an array of test to monitor and diagnose different diseases.

LAMEA IVD Market report it provides a vital recent industry data which covers in LAMEA market situation along with future scenario for industry around the LAMEA. It also consists of major data along with forecasts of a LAMEA market along with clear presentation of diagrams (charts and tables).

According to a new report published by Allied Market Research, titled, “LAMEA IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023”

The LAMEA IVD Market accounted for $7,413 million in 2016, and is estimated to reach $10,316 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/4137

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major companies operating in the market adopt product launch as their key development strategy. Companies profiled in this market include, Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson among others.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4137

Key Benefits
• The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
• Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
• It offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the LAMEA market.

LAMEA IVD Market Key Segments:

By Product Type
• Reagents
• Instruments
• Software and Services

By Techniques
• Immunodiagnostics
o Enzyme-Linked Immunosorbent Assay (ELISA)
 Chemiluminescence Immunoassays (CLIAS)
 Fluorescence Immunoassays (FIAS)
 Colorimetric Immunoassays (CIS)
o Rapid Tests
o Enzyme-Linked Immunospot Assays (ELISPOT)
o Radioimmunoassay
o Western Blot
• Blood Testing
• Molecular Diagnostics
o Polymerase Chain Reaction (PCR)
o Isothermal Nucleic Acid Amplification Technology (INAAT)
o Hybridization
o DNA Diagnostics
o Microarrays
o Others
• Tissue Diagnostics
• Clinical Chemistry
o Basic Metabolic Panel
o Liver Panel
o Lipid Profile
o Thyroid Function Panel
o Renal Profile
o Electrolyte Panel
o Specialty Chemicals
• Other IVD Techniques

By Application
• Infectious Diseases
• Cancer
• Cardiac Diseases
• Immune System Disorders
• Nephrological Diseases
• Gastrointestinal Diseases
• Other Indications

By End Users
• Standalone Laboratory
• Hospitals
• Academic and Medical Schools
• Point of Care Testing
• Others

By Region
• North America
o U.S.
o Canada
o Mexico

• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe

• Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific

• LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.